FDA — authorised 12 October 1966
- Application: NDA016144
- Marketing authorisation holder: ALLERGAN
- Local brand name: ETHAMIDE
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Ethamide in United States
FDA authorised Ethamide on 12 October 1966
Marketing authorisations
FDA
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
FDA
- Application: NDA011047
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: CARDRASE
- Indication: TABLET — ORAL
- Status: approved
Ethamide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Ethamide approved in United States?
Yes. FDA authorised it on 12 October 1966; FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Ethamide in United States?
ALLERGAN holds the US marketing authorisation.